Search
+
    SEARCHED FOR:

    VARIABLE-COST

    United Breweries Q2 sales dip 3% as heavy monsoon hits key markets

    United Breweries reported a 3% year-on-year decline in Q2 sales volume and value, hit by an “unusual monsoon” that flooded three breweries and hurt demand in key states like Karnataka, Odisha, and Telangana. Premium brands, however, grew 17%.

    ET Soonicorns Summit 2025: How founders are choosing profitability over pure valuation chasing

    At ET Soonicorns Summit 2025, founders across EVs, co-living, SaaS, fintech, edtech, and healthtech shared candid insights on scaling responsibly. Emphasising unit economics, disciplined growth, and sustainability, they argued that prioritising profitability and customer value matters more than chasing unicorn status.

    Which stock market sector gave the most returns in the last 8 quarters? Here’s a performance tracker

    From cement’s 71% surge to healthcare’s 34% plunge—our 8-quarter sectoral tracker reveals why putting all eggs in one basket is a costly mistake in today’s polarised market. By Sameer Bhardwaj.

    UltraTech Cement Q1 Results Preview: PAT may jump 30% YoY on cost gains, higher volumes

    UltraTech Cement is expected to post a 30% YoY rise in Q1FY26 profit, with revenue likely up 18%, driven by acquisitions, modest price hikes, and operational efficiency. Brokerages forecast 12–18% volume growth, with EBITDA/tonne seen rising across the board. While costs are slightly higher, improved realisations and scale benefits are expected to support margins.

    Investing is easy, but hard to implement? Sanjay Bakshi explains the rules for value investors

    Sanjay Bakshi emphasizes the importance of having a disciplined approach to investing by constructing filters to reject stocks that don't make sense. He highlights the behavioral challenges of investing and the necessity of focusing on business analysis over market analysis. He also notes the growth potential in India's expanding market, advising investors to concentrate on high-quality businesses.

    Gen-AI is a massive tailwind for our business; expect to improve on industry growth rate of 12%: IKS Health Management

    IKS Health, a healthcare platform serving 18% of US physicians, projects exceeding the industry's 12% growth rate. They aim for 30%+ EBITDA margins within two years, driven by tech leverage and the AQuity acquisition. Confident in long-term growth, they emphasize a large total addressable market and the potential of generative AI.

    The Economic Times
    BACK TO TOP